Table 3.
Indicators of feasibility
| Indicator | Survey 1 at 10 weeks, % (95% CL) |
|---|---|
| Heard about campaign in advance, HH response | 96.7 (94.4–99.0) |
| MDA team reached house to offer meds, HH response | 94.8 (91.8–97.8) |
| Individuals who did not take MDA medications | 10.4 (8.0–12.7) |
| Reasons for not taking medications (n = 134; unweighted) | Absent/not living there, 61.2 |
| Ineligible/excluded, 17.9 | |
| Refused (attitude/perception), 14.9 | |
| Refused (misperception of allowable medical condition), 4.5 | |
| Unspecified, 1.5 | |
| IRS team reached house to offer spray (no OU 14), HH response | 63.5 (57.4–69.7) |
| Wall material suitable for IRS (n = 257)* | Sprayable, 63.6 (59.4–67.8) |
| Could not be sprayed, 36.4 (32.2–40.6) | |
| Eligible houses not sprayed | 8.3 (7.7–8.9) |
| Reasons for not spraying eligible houses (n = 788)† | Refused, 33.0% |
| Unable to vacate house because of illness, 17.6 | |
| Head of HH unavailable for consent, 16.5 | |
| House closed, no one available, 8.4 | |
| Structure no longer a residence, 3.0 | |
| Miscellaneous or unspecified, 20.8 | |
| Both MDA/IRS teams reached house to offer intervention (no OU 14), HH response | 59.1 (53.4–64.9) |
CL = confidence limit; HH = household; IRS = indoor residual spraying; MDA = mass drug administration; OU = operational unit.
*
Estimate collected at 14 months. IRS team reached HH to offer spray: 70.3% (95% CL, 54.2–76.5).
†
Data source: Abt Associates, IRS campaign monitoring report, 2018 (unpublished report).